Form 4: CareCloud Director Bill Korn Reports Equity Transactions and New RSU Grant

CareCloud, Inc. Director Bill Korn reported the acquisition of 7,500 common shares through RSU vesting and a new grant of 25,000 restricted stock units.

Summary

• Bill Korn, a Director of CareCloud, Inc. (CCLD), reported changes in his beneficial ownership.
• Acquired 7,500 shares of common stock on August 1, 2025, through the vesting and conversion of restricted stock units. These shares were acquired without payment under the Company's Amended and Restated Equity Incentive Plan.
• Received a new grant of 25,000 restricted stock units (RSUs) on July 31, 2025.
• The newly granted RSUs will vest in four equal installments on January 31, 2026, July 31, 2026, January 31, 2027, and July 31, 2027.
• Following these transactions, Bill Korn beneficially owns 190,383 shares of common stock and 47,500 restricted stock units.

Sentiment

Score: 7

Explanation: The filing indicates routine equity compensation and increased director ownership, which is generally positive for aligning interests, but does not contain significant new strategic or financial information to warrant a higher score.

Positives

• Director Bill Korn's beneficial ownership of common stock increased by 7,500 shares to 190,383 shares, indicating continued alignment with shareholder interests.
• A new grant of 25,000 restricted stock units to a director suggests ongoing commitment and incentivization of key management.

Future Outlook

The vesting schedule for the newly granted restricted stock units extends through July 31, 2027, indicating a long-term incentive structure for the director.

Industry Context

This Form 4 filing reflects standard equity compensation practices within the healthcare technology sector, where restricted stock units are commonly used to align the interests of directors and executives with long-term shareholder value.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a form of equity compensation for directors is a common practice across publicly traded companies, including those in the healthcare technology industry.
• Companies like Teladoc Health (TDOC), Amwell (AMWL), and Veeva Systems (VEEV) frequently utilize similar equity incentive plans to attract, retain, and incentivize key personnel, aligning their interests with long-term company performance.
• The vesting schedule over multiple years is also standard, promoting sustained commitment rather than short-term gains.

Stakeholder Impact

• Shareholders: Increased director ownership aligns management interests with shareholders, potentially fostering long-term value creation.
• Employees: The equity incentive plan demonstrates the company's commitment to using equity as a compensation tool, which can be a positive for employee retention and motivation if similar plans are available to other employees.

Next Steps

• Future vesting of 25,000 restricted stock units in four equal installments on January 31, 2026, July 31, 2026, January 31, 2027, and July 31, 2027.

Key Dates

Recommendation

The filing details routine equity compensation for a director, including the vesting of restricted stock units and a new RSU grant. These transactions are standard practice and do not provide new information that would significantly alter the company's fundamental outlook or warrant a change in investment recommendation. It primarily indicates continued alignment of director interests with the company's long-term performance.

Keywords

CareCloud, CCLD, Form 4, SEC filing, beneficial ownership, restricted stock units, equity compensation, insider trading, director ownership